# Mylan Teoranta – FDA Inspection, Feb 16, 2018

Source: https://www.keypedia.com/records/fda_inspections/mylan-teoranta/af6aed52-4b5e-4a40-8994-3c57e1737204
Source feed: FDA_Inspections

> FDA inspection 1041657 of Mylan Teoranta, February 16, 2018. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 211. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1041657
- Company Name: Mylan Teoranta
- Inspection Date: 2018-02-16
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1202025 - 2022-07-15
- FDA Inspection 1123541 - 2018-06-22
- FDA Inspection 978312 - 2016-06-15
- [FDA Inspection 886146 - 2014-05-27](https://www.keypedia.com/records/fda_inspections/mylan-teoranta/b043bac6-5e98-4334-9237-2d1fd03c5f93)
- FDA Inspection 782346 - 2012-03-30

## Related Officers

- [Saleem A. Akhtar](https://www.keypedia.com/people/saleem-a-akhtar/1ea49212-bea5-4d43-bd0a-cdede4d3b1cf)

Company: https://www.keypedia.com/companies/mylan-teoranta/070856c0-ee70-4d73-a354-2afd7aa24c14

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c